Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!! -- Ignore unavailable to you. Want to Upgrade?

To: (no name provided) who wrote (147)	6/5/1998 1:03:00 PM
From: Cindy Powell	Respond to of 196

Medical Discoveries, Inc., and Advanced Bio-Technologies Establish New 'Cosmeceuticals' Joint Venture Company PR Newswire - June 05, 1998 12:48 MLSC %MTC %JVN %PDT V%PRN P%PRN ------------------------------------------------------------------------ LAYTON, Utah, June 5 /PRNewswire/ -- Medical Discoveries, Inc., (OTC Bulletin Board: MLSC) announced it has agreed in principle with Advanced Bio-Technologies, Inc., to establish a new company, Regenere(TM) Inc., (pronounced "ray jen air", French meaning "to revitalize"). Regenere(TM) will focus on the development and commercialization of a new generation of patented wound care and skin repair "cosmeceuticals" for repairing, restoring and revitalizing damaged skin. Advanced Bio-Technologies, Inc., ("ABT") of Silverdale, Washington is a privately held corporation specializing in the research, development and sales of silicone based wound treatment and related skin care products. The company's flagship product is Kelo-cote(R) a clinically proven silicone topical gel which aids in the rapid healing and reduction of scar tissue resulting from cuts, burns and abrasions, as well as effectively and dramatically reducing the appearance of older scars. Medical Discoveries, Inc., ("MDI") through its Japan and USA based research and development teams, has been developing a new generation of wound cleansing and skin care products based on its proprietary core technologies. MDI and ABT are transferring their existing skin care products into Regenere(TM), Inc., and will focus combined research and product development into additional innovative products for wound healing and skin care. ABT President and CEO, Alvin S. Berlat explained "Kelo-cote(R) is a unique product which protects wounds and promotes rapid healing, and has the proven ability to reduce the appearance of older scars. Unlike "silicone sheeting" products which must be taped over the scar, Kelo-cote(R) is a gel which when applied becomes invisible, allowing the skin to breath while acting as a barrier to waterborne bacteria. Kelo-cote(R) is the only patented product of its type available. The formation of Regenere(TM) enables us to introduce a complete "cosmeceutical system" for wound care and skin repair." "The creation of Regenere(TM) represents a commitment to become the world's leading innovator and supplier of a new generation of "cosmeceuticals" targeted at repairing, restoring and revitalizing damaged skin," stated MDI President and CEO, Lee F. Kulas. "This joint venture brings both MDI and ABT to share technologies, collaborate on scientific research, and energize product development and rapid introduction in the fast growing "cosmeceuticals" marketplace and is the first step of a corporate strategy to move certain aspects of our core technologies into consumer focused, revenue producing, emerging markets, while pursuing FDA approvals on our MDI-P compound targeted at anti-bacterial, anti-fungal and anti-viral (HIV/AIDS) applications." SOURCE Medical Discoveries, Inc. /CONTACT: Press only: Alvin S. Berlat of Advanced Bio-Technologies, Inc., 360-698-2266, or Analysts Only: Marlin Toombs, Director, Investor Relations of Medical Discoveries, Inc., 801-771-0523/ /Web site: mdi-p.com (MLSC)

To: (no name provided) who wrote (147)	6/5/1998 8:37:00 PM
From: Cindy Powell	Read Replies (1) \| Respond to of 196

Welcome on board Stepannick! I agree with your reasoning that scientists and management of this calliber wouldn't have joined MLSC if they hadn't recognized something compelling, exciting and promising in the MDI-P. Beings how there are literally 100's of uses for the MDI-P and the variations are being promptly secured with patent protection, I think we have a sure-fire winner. I know how excited to get now! Very! :o) Thankyou for your thoughts and information regarding Dr. Bill Novick. I like the line upon line, precept upon precept approach to science also, and Dr. Novick's experience and education with Hoechest and Duke only increases my confidence. It might be interesting to note that the two top Electrolized Water scientists in Japan are also part of MLSC's team. We definitely have a winner here. Best regards, Cindy